To the Editor,
Many recent studies have demonstrated that the umbilical cord is an excellent source of mesenchymal stem cells (MSCs) [1, 2, 3] . However, in order to use human umbilical cord Wharton's jellyderived mesenchymal stem cells (hUC-MSCs) in clinical therapy, a suitable culture procedure for good manufacturing practicecompliant production is mandatory. Nutritional deficiency is the major pathophysiological situation in an ischemic microenvironment in the clinic [4] . Thus, the development of serum-free culture systems is needed [5] . Furthermore, hypoxia is common in vivo in mammals [6] . The average oxygen tension falls to 1% in some cases of pathological ischemia, including fracture hematoma, and in cases of myocardial ischemia [7] . Hence, the investigation of biological characteristics of hUC-MSCs exposed to hypoxic and/or serum-free conditions is of great interest.
In our study, we conducted parallel assays by using four cell groups. For the hypoxic controls, cells from group A (n=10) and group B (n=10) were exposed to 5% CO 2 and 94% N 2 in an airtight modular incubator chamber (Billups-Rothenberg Inc., Del Mar, CA, USA). The final oxygen tension was 1%-3% as measured by an oximeter (Oxybaby M+, Witt Technology, Solza, Italy). For the normoxic controls, cells from group C (n=10) and group D (n=10) were placed in an incubator at 37 °C, 5% CO 2 , and 21% O 2 . Cells from group A and group C were expanded in a mixture of Dulbecco's modified Eagle's medium and nutrient mixture F-12 (GIBCO, USA) supplemented with 10% fetal bovine serum (GIBCO, USA). Cells from group B and group D were expanded in StemPRO MSC serum-free medium (StemRD, USA). Flow cytometric analysis, differentiation potential, proliferative activities, cell cycle analysis, and apoptosis analysis of these four cell populations were evaluated. We repeated all these experiments 3 times.
Flow cytometry analysis of MSC-specific surface marker expression showed that hUC-MSCs cultured under four experimental conditions for six passages were positive for CD44, CD73, CD90, CD105, CD29, and HLA-ABC (BD Pharmingen, USA) and negative for CD34, CD45, CD14, and HLA-DR (BD Pharmingen, USA); no significant differences were detected between the four cell populations ( Figure  1 ). This finding indicates that culturing cells under hypoxic and/or serum-free conditions did not induce significant variations in the typical MSC marker expression profile. hUC-MSCs maintained their multilineage differentiation potential in vitro after expansion under various conditions [8] . MSCs from all groups demonstrated a similar osteogenic phenotype, as evidenced by positive staining for alizarin red S (Sigma-Aldrich, USA) and deposits of calcified matrix (Figure 2 ). In the case of adipogenic differentiation, cells from all groups formed lipid vacuoles detected by oil red O (Sigma-Aldrich, USA). There were no significant quantitative changes among the groups (Figure 3) . Thus, the results presented in this report indicate that hypoxic and/or serum-free conditions do not affect the biological characteristics of hUC-MSCs. Under hypoxic and serum-free conditions, hUC-MSCs have higher proliferation according to their growth curves (BD Pharmingen, USA) and MTT assays (BD Pharmingen, USA) than cells grown under normoxic and serum-containing culture conditions, but without more apoptosis (Figures 4 and 5) . Taken together, our data indicate that hypoxic and serum-free culture conditions do not influence the major properties of hUC-MSCs. Under hypoxic and serum-free conditions, hUC-MSCs showed higher proliferation, while their apoptosis rate did not increase. This finding is consistent with that of previous reports, which demonstrated enhanced proliferation of bone marrow-derived MSCs (BM-MSCs) under hypoxic or serumfree conditions [9, 10] . Therefore, the availability of optimized in vitro conditions, including hypoxia and serum-free media, for hUC-MSC manipulations may have a substantial scientific and clinical impact. 
